Value of Combined Detection of CA19-9 and CEA with Electrochemiluminescence in Diagnosis of Pancreatic Cancer

Objective To investigate the clinical value of the tumor marker CA19-9 and carcinoembryonic antigen(CEA) in human serum in diagnosis of pancreatic cancer.Method The concentrations of CA19-9 and CEA in serum in thirty-two patients with pancreatic cancer and thirty-two patients with benign pancreatic disease were detected with Elecsys 1010 auto electrochemiluminescene immune analyzer.Results The levels of CA19-9 and CEA in the former group were 106.3±79.1ng/ml and 31.8±0.7ng/ml,which were significantly higher than those in the latter group.Conculsions The value of CA19-9 in diagnosis of pancreatic cancer is higher than that of CEA.But the combined detection of CA19-9 and CEA is clinically significant to diagnosis of pancreatic cancer.